Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Símbolo de cotizaciónTMCI
Nombre de la empresaTreace Medical Concepts Inc
Fecha de salida a bolsaApr 23, 2021
Director ejecutivoMr. John T. Treace
Número de empleados477
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 23
Dirección100 Palmetto Park Place
CiudadPONTE VEDRA
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal32081
Teléfono19043735940
Sitio Webhttps://www.treace.com/
Símbolo de cotizaciónTMCI
Fecha de salida a bolsaApr 23, 2021
Director ejecutivoMr. John T. Treace
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos